Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study.
J Immunother Cancer
; 10(3)2022 03.
Article
in En
| MEDLINE
| ID: mdl-35288468
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tumor Microenvironment
/
Neoplasms
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
J Immunother Cancer
Year:
2022
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Reino Unido